STAGE IV LUNG CANCER
Clinical trials for STAGE IV LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple blood test predict who responds to immunotherapy?
Knowledge-focused Recruiting nowThis study from Mayo Clinic is looking at how T cells (a type of immune cell) change during anti-PD-1 immunotherapy in people with advanced melanoma, lung cancer, or other solid tumors. Researchers will collect blood and tissue samples from 500 participants to measure specific ma…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Real-World study tracks osimertinib combo for lung cancer
Knowledge-focused Recruiting nowThis study is watching how patients with EGFR-mutated non-small cell lung cancer do when they receive standard treatment with osimertinib (Tagrisso) alone or with chemotherapy in routine medical practice. About 538 people with advanced lung cancer will be followed to see how long…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: PrECOG, LLC. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC